drugset / Trial / NCT04877093

Repurposing Low-Dose Clonidine for PTSD in Veterans

NCT04877093

Phase 3 Recruiting 32 enrolled Wake Forest University Health Sciences
RandomizedCrossoverQuadruple-blindTreatment

Summary

Hypothesis: Veterans with PTSD prescribed clonidine will demonstrate improvements in PTSD symptoms, including daytime, nighttime, and sleep-related behaviors.

Timeline

Start
2023-06-01
Primary completion
2027-03-31
Completion
2027-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 0.1 mg